Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2023-10-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, InnoTherapy, detailing a decision for a third-party capital increase (유상증자결정). This type of filing is a mandatory regulatory disclosure to the Financial Services Commission and the Korea Exchange regarding changes in capital structure and share issuance. It falls under the category of share issuance/capital change announcements.
2023-10-25 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). This type of filing details the company's repurchase of its own debt instruments (convertible bonds) due to a put option exercise. Since this relates to the company's capital structure and financing activities, it falls under the 'Capital/Financing Update' category.
2023-10-12 Korean
주요사항보고서(유형자산양도결정)
Regulatory Filings Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange by InnoTherapy Co., Ltd. It details a specific corporate decision regarding the disposal of tangible assets (real estate). In the context of Korean regulatory filings (DART system), this type of disclosure regarding asset disposal is a standard regulatory filing that does not fit into specific categories like earnings releases or annual reports, thus falling under the general regulatory filing category.
2023-09-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically reporting a change in the representative reporter due to a corporate split (spin-off) of SCL Healthcare. This falls under the category of Major Shareholding Notification as it tracks significant ownership thresholds and changes.
2023-08-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report changes in shareholdings by major shareholders or insiders. In the provided taxonomy, 'Director's Dealing' (DIRS) covers personal share transactions by company directors and executives, and 'Major Shareholding Notification' (MRQ) covers changes in significant share ownership levels. Given the document explicitly identifies the reporter as a '10% or more shareholder' (10%이상주주) and details the change in their ownership stake, it fits the definition of a Major Shareholding Notification.
2023-08-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by SCL Holdings and the Seoul Clinical Laboratories Foundation in InnoTherapy Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2023-08-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.